AU2001271732A1 - 25869, a human carboxylesterase and uses thereof - Google Patents

25869, a human carboxylesterase and uses thereof

Info

Publication number
AU2001271732A1
AU2001271732A1 AU2001271732A AU7173201A AU2001271732A1 AU 2001271732 A1 AU2001271732 A1 AU 2001271732A1 AU 2001271732 A AU2001271732 A AU 2001271732A AU 7173201 A AU7173201 A AU 7173201A AU 2001271732 A1 AU2001271732 A1 AU 2001271732A1
Authority
AU
Australia
Prior art keywords
human carboxylesterase
carboxylesterase
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271732A
Inventor
Rory A. J. Curtis
Thomas Joseph Logan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001271732A1 publication Critical patent/AU2001271732A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU2001271732A 2000-06-29 2001-06-29 25869, a human carboxylesterase and uses thereof Abandoned AU2001271732A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21537000P 2000-06-29 2000-06-29
US60/215,370 2000-06-29
PCT/US2001/020968 WO2002002760A2 (en) 2000-06-29 2001-06-29 25869, a human carboxylesterase and uses thereof

Publications (1)

Publication Number Publication Date
AU2001271732A1 true AU2001271732A1 (en) 2002-01-14

Family

ID=22802723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271732A Abandoned AU2001271732A1 (en) 2000-06-29 2001-06-29 25869, a human carboxylesterase and uses thereof

Country Status (4)

Country Link
US (1) US20020076786A1 (en)
EP (1) EP1297155A2 (en)
AU (1) AU2001271732A1 (en)
WO (1) WO2002002760A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1756280T3 (en) 2004-04-22 2015-02-02 Commw Scient Ind Res Org SYNTHESIS OF CHAIN, polyunsaturated fatty acids BY RECOMBINANT CELLS
CA2563875C (en) 2004-04-22 2015-06-30 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US8816106B2 (en) 2006-08-29 2014-08-26 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids
KR100975852B1 (en) * 2008-03-14 2010-08-13 연세대학교 산학협력단 Composition for liver cancer diagnosis comprising liver carboxylesterase 1-specific antibody
CA2743880C (en) 2008-11-18 2020-08-18 James Robertson Petrie Recombinant cells comprising exogenous a5 elongase and methods for producing docosapentaenoic acid
WO2011011528A1 (en) * 2009-07-23 2011-01-27 Musc Foundation For Research Development Isopropylphenidate for the treatment of attention-deficit/hyperactivity disorder and fatigue-related disorders and conditions
WO2012145514A2 (en) * 2011-04-20 2012-10-26 University Of Florida Research Foundation Inc. Compositions and methods for genotyping ces1 genetic variants and use thereof
AU2013273934B2 (en) 2012-06-15 2016-12-01 Commonwealth Scientific And Industrial Research Organisation Production of long chain polyunsaturated fatty acids in plant cells
JP6726619B2 (en) 2013-12-18 2020-07-22 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション Lipids containing long-chain polyunsaturated fatty acids
CA2953008C (en) 2014-06-27 2024-03-19 Nuseed Pty Ltd Lipid comprising docosapentaenoic acid
EP3833980A1 (en) 2018-08-10 2021-06-16 F. Hoffmann-La Roche AG Ces-2 (carboxylesterase-2) for the assessment of afib related stroke

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042593A1 (en) * 1998-02-19 1999-08-26 St. Jude Children's Research Hospital Compositions and methods for sensitizing and inhibiting growth of human tumor cells
CA2350388A1 (en) * 1998-11-12 2000-05-18 Incyte Pharmaceuticals, Inc. Human hydrolase proteins

Also Published As

Publication number Publication date
EP1297155A2 (en) 2003-04-02
WO2002002760A2 (en) 2002-01-10
US20020076786A1 (en) 2002-06-20
WO2002002760A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2001271732A1 (en) 25869, a human carboxylesterase and uses thereof
AU2001261572A1 (en) 38594, a novel human transporter and uses thereof
AU2001268561A1 (en) 22109, a novel human thioredoxin family member and uses thereof
AU2001263492A1 (en) 21956 and 25856, human aminopeptidases and uses thereof
AU2001259271A1 (en) 14094, a novel human trypsin family member and uses thereof
AU2001249700A1 (en) 33167, a novel human hydrolase and uses therefor
AU2001268440A1 (en) 53320, a human acyltransferase and uses therefor
AU2001288606A1 (en) 8797, a human galactosyltransferase and uses thereof
AU2001275310A1 (en) 46980, a novel human neuroligin family member and uses thereof
AU2001243447A1 (en) 16835, a human phospholipase c and uses thereof
AU2002232644A1 (en) 53010, a human carboxylesterase family member and uses thereof
AU2001296325A1 (en) 47647, a human lipase and uses therefor
AU2002211365A1 (en) 22437, a human sulfatase and uses therefor
AU2001285461A1 (en) 38618, a human alpha/beta hydrolase and uses thereof
AU2001286757A1 (en) 46863, a human methyltransferase and uses thereof
AU2001263233A1 (en) 57805, a novel human cadherin family member and uses thereof
AU2001268435A1 (en) 23680, a novel human aminotransferase and uses therefor
AU2001263237A1 (en) 57256 and 58289, human transporters and uses thereof
AU2001296307A1 (en) 55054, a human metalloprotease and uses therefor
AU2001291221A1 (en) 55063, a human nmda family member and uses thereof
AU2002211492A1 (en) 57800, a novel human cadherin and uses therefor
AU2001276025A1 (en) 25233, a human aminotransferase and uses therefor